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ABSTRACT 
Asthma is a wide speared disease all over the world. In this disease breathing is not smooth due to contraction of bronchitis.  
Ventolin  is  an  effective  drug  for  this  purpose  and  is  widely  used.  Its  active  ingredient  is  Salbutamol  Sulphate,  which  is 
bronchodilator. Due to oxygen and nitrogen donor sites of Salbutamol (Fig I), it has been assumed that it may interact with metals 
present in the biological system, and therefore disturb the metals metabolism and imbalance the equilibrium. On the other hand 
two third of the body’s iron is found in hemoglobin which is an oxygen storage protein. Therefore may iron is chelated by the 
Salbutamol ion in the stomach. The chelation of iron by salbutamol, stability of the complex and Stoichiometry at acidic pH of the 
said complex is investigated implied Spectrophotometric technique. Salbutamol formed highly colored complex with iron having 
maximum absorbance at 550nm. A 1:3 complex formation in buffered and non buffered solutions at 30°C was found using mole 
ratio and slope ratio methods.  Molar extinction coefficients were determined by calibration curve method and was found very 
high in non buffered solution comparative to buffered solutions. Stability constant of ML1  is found 6.3635,  ML2 is 11.919 and 
ML3 is 16.858 in non buffered solution. Closer ln values were found in buffer of pH 3.0 and 3.5. 
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1. INTRODUCTION 
Asthma affects 6 million children in the United States and 16 million people’s total
1. There are two factors which 
provoke asthma, triggers and inducers. Triggers irritate the airways and result in bronchoconstriction. The Common 
triggers include everyday stimuli such as: cold air, dust, strong fumes, exercise, inhaled irritants, emotional upsets and 
smoke
2-3. The last one is the strongest trigger. Common inducers are Allergens and Respiratory viral infection
4-6. In 
contrast  to  triggers,  inducers  cause  both  airway  inflammation  and  airway  hyper  responsiveness  and  hence  are 
recognized as causes of asthma
7-9. 
  These symptoms can easily be relieved by a bronchodialator such as ventolin® (containing salbutamol 
sulphate). salbutamol form the initial therapy of chronic as well as acute asthma
10. 
Myoglobin an iron containing protein functions in the transport and short-term storage of oxygen in muscle cells, 
helping  to  match  the  supply  of  oxygen  to  the  demand  of  working  muscles
11.  Since  Salbutamol  is  used  as 
bronchodialator  for  asthmatic  patients.  There  is  strong  possibility  that  Fe(III)  may  react  with  Salbutamol,  could 
enhance its effectiveness. 
  In the present study chelation of Fe(III) by salbutamol is investigated. Chelation, stoichiometry, stability 
and molar extinction coefficients were determined by spectrophotometric technique in non buffered as well as buffer 
of pH 3.0 and 3.5.  
  Evaluation of chelation strength of Fe(III) by the drug molecule at stomach pH will provide important 
guideline to understand the maintenance of drug’s efficacy as well as accomplishment of iron. 
  
 
 
 
 
 
 
Fig-1: – (Dimethylethyl) amino]methyl]-4-hydroxy-1,3-benzenedimethanol 
 
2. RESULTS AND DISCUSSION 
A  complex  solution  of  known  concentration  was  scanned  on  Thermogenesys  6  Spectrophotometer,  absorbance 
maxima was found at 550.nm in buffer solution of  pH 3.0, 3.5 and in non buffered solutions as well. 
 
2.1 Molar extinction coefficients  
Molar extinction coefficients of the complex at different working conditions were found by calibration curve method 
(Fig-2). In this method a tenfold excess of ligand is added to the metal solution. Different dilutions of the complex 
solutions are then prepared and the absorbances were recorded at the selected wavelength (550.0nm). Graph between Pakistan Journal of Chemistry, 2012 
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concentration of complex and the respective absorbance were plotted (Fig-2). Based on the implementation of the 
Beer’s law, A = εbC, the straight line obtained passed through the origin and the slope of the line represented the 
molar extinction coefficient, ε (Fig-2). The value is almost same in pH 3.0 and 3.5 buffered solutions while about 10 
times higher in non buffered solution (Table-I). 
 
Table-1:  Molar extinction coefficients of the complex at different working conditions 
S. No  Working Media  Molar Extinction Coefficients (ε)    (M
-1cm
-1) 
1  Buffer pH 3.0  103.07 
2  Buffer pH 3.5  102.54 
3  Non buffered Media  1201.32 
 
 
 
Fig-2: Calibration Curve for the Evaluation of Molar Extinction Coeff icient of Iron(III)-Salbutamol complex in buffer of pH 3.0; 
Temperature = 30±2°C, max =550 nm. 
 
2.2 Stoichiometry 
The  sample  solutions  prepared  were  comparative  to  each  other  through  the  Ligand/Metal  ratio  and  their 
absorbances were analyzed. Absorbance was gradually increases with the rise of ligand concentration (Fig-3) 
while level off at higher concentration. Tangents drawn to this curve gave an idea about the mole ratio between 
Fe (III) and Salbutamol which is found 1:3 regardless of solvent media (Fig-4,5). 
 
M(H2O)6
3+   +  3L
-1/-2               [ML3]
n-
       +      6H2O 
 
 
 
 
Fig-3:  Mole ratio plot for Iron(III)-Salbutamol complex in buffer of pH 3.0; Concentration of Fe(III) = 1.25 mM. 
Temperature = 30±2°C, max =550 nm. 
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Fig-4:  Mole ratio plot for Iron(III)-Salbutamol complex in buffer of pH 3.5; Concentration of Fe(III) = 1.25 mM. 
Temperature = 30±2°C, max =550 nm. 
 
 
 
 
Fig-5:  Mole ratio plot for Iron(III)-Salbutamol complex in aqueous media; Concentration of Fe(III) = 1.25 mM. 
Temperature = 30±2°C, max =550 nm. 
 
 
2.3 Slope Ratio Method 
Stability of complexes depends strongly upon nature of ligand regardless of many other factors. In case of pH 3.0, 
computational studies of the spectrphotometric data (of Fig-2) was carried to determine stability constants ()
13-14. 
Same studies were done in working conditions of pH 3.5 buffer and in non-buffered solutions. 
 
Since 1:1, 1:2 and 1:3, M:L species were formed during the spectrphotometric titration. Therefore, 
 
1 = 
[ML]  -----------------Equation (1)  [M]r [L]r 
 
Similarly 
2  = 
[ML2]              -----------------Equation (2)  [M]r [L]r
2 
 
and
 
 
3 = 
[ML3]               -----------------Equation (3)  [M]r [L]r
3 
 
Taking ln on both sides of the equation (1) 
ln 1 = ln ([ML]/ [M]r [L1]r
 ) 
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ln 1 = ln ([ML]/ [M]r)  - ln [L1]r
 ) 
 
ln ([ML]/ [M]r) =   ln [L1]r
  + ln 1  -----------------Equation (4) 
 
According to the equation of straight line, 
y = m x + c 
 
 By plotting a graph between ‘x’ and ‘y’, a straight line was obtained. The slope of the line is denoted by ‘m’ whereas 
‘c’ represents the intercept. 
Applying straight line equation on equation (4), a linear graph is observed between ln[L1]r and ln ([ML]/ [M]r) 
(Fig-6,9,12). Therefore the intercept of the line represents ‘ln’ and the slope gives the mole ratio of metal and 
ligand
13-14.  Using  equation  2  and  3  in  the  same  manner  ln2  and  ln3  of  ML2  and  ML3  were  determined  (Fig-
7,8,10,11,13,14). 
 
 
 
 
Fig-6:  Plot for formation constant of ML1 complex in buffer of pH 3.0. 
Intercept = 5.9348, Slope =1.0761 
 
 
 
Fig-7: Plot for formation constant of ML2 complex in buffer of pH 3.0. 
Intercept = 12.401, Slope =2.1986 
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Fig-8:  Slope ratio Plot of formation constant for ML3 complex in buffer of pH 3.0. 
Intercept = 16.412, Slope = 2.8996 
 
 
Fig-9: Plot for formation constant of ML1 complex in buffer of pH 3.5. 
Intercept = 5.9336, Slope =1.0945 
 
 
 
Fig-10: Plot for formation constant of ML2 complex in buffer of pH 3.5. 
Intercept = 12.123, Slope = 2.1349 
y = 2.1349x + 12.123 
-2 
-1.5 
-1 
-0.5 
0 
0.5 
1 
1.5 
2 
2.5 
3 
3.5 
-7  -6  -5  -4  -3  -2  -1  0 
ln[L]r 
y = 1.0945x + 5.9336 
-3 
-2 
-1 
0 
1 
2 
3 
4 
-9  -8  -7  -6  -5  -4  -3  -2  -1  0 
ln[L]r 
y = 2.8996x + 16.412 
-1.5 
-1 
-0.5 
0 
0.5 
1 
1.5 
2 
2.5 
3 
3.5 
-7  -6  -5  -4  -3  -2  -1  0 
ln[L]r 
ln([ML]/[M]r) 
ln([ML]/[M]r) 
ln([ML]/[M]r
) Pakistan Journal of Chemistry 2012 
 
96 
 
 
Fig-11: Plot for formation constant of ML3 complex in buffer of pH 3.5. 
Intercept = 17.055, Slope = 3.0529 
 
 
Fig-12: Plot for formation constant of ML1 complex in aqueous media. 
Intercept = 6.3625, Slope = 1.1644 
 
 
 
Fig-13: Plot for formation constant of ML2 complex in aqueous media. 
Intercept = 11.919, Slope = 1.9721 
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Fig-14: Plot for formation constant of ML3 complex in aqueous media. 
Intercept = 16.858, Slope = 2.7823 
 
 
By the help of this method, ln  of respective complexes at different pH conditions were explored and summarized in 
Table-2. 
 
Table-2: Stability Constants of Fe(III)-Salbutamol Comlexes 
S. No  Solvent media  ln 
ML1  ML2  ML3 
1  Buffer of pH 3.0  5.9348  12.401  16.412 
2  Buffer of pH 3.5  5.9336  12.123  17.055 
3  Non-buffered Solution  6.3635  11.919  16.858 
 
3. EXPERIMENTAL 
All reagents used were of A. R. grade. Throughout the experiments, temperature was maintained at 30°C + 2°C. 
Known amount of Ferric sulfate was weighed carefully on an analytical balance SHIMADZU Model No. AUW 220, 
and dissolved in de-ionized distilled water with a small volume of concentrated hydrochloric acid for acidification. 
The final volume was then made up to 250.0ml.  
This  Fe  (III)  solution  was  standardized  using  hydroquinone  and  1,10-orthphenanthroline  solutions  after 
addition of Na-NaCH3COO buffer
12.  
Stock solution of Salbutamol sulphate for known concentration were prepared in de-ionized distilled water by 
dissolving  calculated  amount  of    AR  grade  reagent.  Different  dilutions  of  the  stock  solutions  were  then  made 
according to the requirement of the experiments. For each and every set fresh solution were prepared to avoid the 
expected oxidation of ligand molecules by air. Same method is used to prepare stock solution in buffer of pH 3.0 and 
3.5. The required buffers of pH 3.0 and 3.5 were prepared by adding formic acid in standard NaOH, and the pH of 
buffers were maintained by using Jenway model No. 370 having  a resolution of + 0.01. 
The prepared solutions (in each media i.e. pH 3.0, pH 3.5 and in de-ionized distilled water) of  metal salt, 
ligand and their complex were scanned between 300nm and 800 nm on the UV-Visible spectrophotometer Thermo  
Genesys 6 in order to find out the Absorbance maxima(max).  
A  complex  solution  which  contain  excess  ligand  than  Fe(III),  showed  significant  absorbance  at  selected 
wavelength. This solution was used for calibration curve method. As the ligand was in excess in the case, it is assumed 
that all the Fe(III) formed complex. Therefore the concentration of the complex is equal to the concentration of the 
metal ion taken initially in th-e sample. 
Different volumes of this complex from 1.0 ml to 10.0 ml were taken and diluted with de-ionized distilled 
water up to a final volume of 10.0ml and their absorbance were recorded. Same procedure was used to find out the 
molar extinction coefficient in buffer of pH 3.0 and 3.5. 
A fixed volume (1.0 ml from stock) of Fe (III) salt solution was taken in different volumetric flasks of 10.0 
ml. Different volumes of the already prepared equimolar solution of Salbutamol sulphate was added to the volumetric 
flasks and their total volume made up with deionized distilled water. An intense violet color Iron (III) – Salbutamol 
complex was observed instantly.  
Absorbances versus ligand to metal ratio were obtained. A graph of which helps to evaluate stoichiometry of 
the complex. Computational method was applied to implement the slope ratio method that explores the stability 
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constants of the complex at experimental conditions
13-14. Same procedure was used for the analysis at pH 3.0 and 3.5. 
For which the final volume of complex solutions were maintained upto a certain value with respective buffers. Each 
experiment in the analysis was repeated at least thrice to obtain accuracy and minimize errors.    
 
4. CONCLUSION 
Salbutamol chelates iron as a bidentate ligand. Three molecules of Salbutamol sulphate bind an Iron satisfying all six 
coordination sites and form an octahedral complex. 
In a buffer of pH 3.0, pH 3.5 and in non-b uffered media, the analysis showed that the mole ratio between iron 
and Salbutamol sulphate comes out to be 1:3, regardless of the pH conditions in which the analysis was carried out. 
The results of pH 3.0 and pH 3.5 are very much similar whereas the molar extinction coefficient in aqueous media is 
very high as compared to the other two. 
The stability constants of ML1, ML2 and ML3 are considerably high although the trend observed was similar 
in all three solvent systems. 
The results showed that at acidic pH (in stomach), salbutamol is able to make strong complex with Ferric ion 
and therefore may create iron deficiency in asthmatic patients. Since literature reported anemia in asthmatic patients, 
the present study is consistent with the result. 
Still the binding sites of the investigated drug molecule has question mark. Complex formation and stability 
constants and stoichiometry affected by increasing pH should be examine and explored.  
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